Supplementary Data from First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain–Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors
Authors:
- Melissa L. JohnsonMJMelissa L. Johnson
- Beni B. WolfBWBeni B. Wolf
- Judy S. WangJWJudy S. Wang
- Alexander PhilipovskiyAPAlexander Philipovskiy
- Geoffrey I. ShapiroGSGeoffrey I. Shapiro
- Bruno BockornyBBBruno Bockorny
- Wei GuoWGWei Guo
- Jinshan ShenJSJinshan Shen
- Kai Yu JenKJKai Yu Jen
- MaryBeth LeRoseMLMaryBeth LeRose
- Tamieka Lauz HunterTHTamieka Lauz Hunter
- Mahesh PadvalMPMahesh Padval
Open Access
- 4 March 2025
- other
- Published by American Association for Cancer Research (AACR)